4 курс / Дерматовенерология / Морфогенетический_подход_к_лечению_угрей_ретиноидами_Ноздрин_В_И

141

68. Шахтмейстер И. Я., Покрышкин В.И., Карагиоз Г. И. и др. Опыт лече-

ния угревой сыпи ретиноидом – роаккутаном // Вестн. дерм. и венер. - 1985, №

8.- С. 8-10.

69.Шишкова М.В. Изучение содержания некоторых половых стероидных гормонов у женщин при акне и метод их коррекции: Автореф. дис. канд. мед.

наук. - М., 2001. - 23 с.

70. Щербаков В.И. Макрофаги: новая функция – росторегулирующая // Успе-

хи совр. биол. - 1990, № 1. - С. 106-119.

71.Эрнандес Е. Витамин А и кожа. Часть 1. Тайна ретинола // Косметика и медицина. - 2000, № 4. - С. 21-33.

72.Язды Шекари Мохамад. Роль микотической инфекции в патогенезе акне

исеборейного дерматита: Автореф. дис. канд. мед. наук. - М., 1996. - 19 с.

73.Яковлева И.М., Вакулова Л.А., Самохвалов Г.И. Метаболизм витамина А.

Структура и синтез метаболитов, их биологическая активность: обзор // Хим.-

фармац. журнал. - 1984. - Т.18, № 4. - С. 391-411.

74.Aizawa H., Nakada Y., Niimura M. Androgen status adolescent women with acne vulgaris // J. Dermatol. - 1995. - V. 22. - P. 530-532.

75.Akamatsu H., Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation // Dermatol. - 1998. - V.196, № 1. - P. 82-85.

76.Alonso A., Meirelles N.C., Yushmanov V.E., et al. Water increases the fluidity of intercellular membranes of stratum corneum: correlation with water permeability, elastic, and electrical resistance properties // J. Invest. Dermatol. –1996. - V. 106, №

5.- P. 1058-1063.

77.Allaker R.P., Greenman J., Osborne R.H. The production of inflammatory compounds by Propionibacterium acnes and other skin organisms // Br.J. Dermatol. - 1987. - V.117. - P. 175-183.

78.Allen B.S., Smith J.G. Various parameters for grading acne vulgaris // Arch. Dermatol. - 1982. - V.118. - P.23-27.

142

79.Ashbee H.R., Muir S.R., Cunliffe W.J., et al. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris // Br. J. Dermatol. - 1997. - V. 136 (5). - P. 730-733.

80.Auffret N. Acne today. What' s new? // Presse Med. - 2000, May 27-Jun 3.- V. 29 (19). - P. 1091-1097.

81.Barkley A.S.J., Bather P.C., Allen B.R. Retinoids enhance monocyte (endothelium interaction) // J. Invest. Dermatol. - 1987. - V. 69. - P. 320.

82.Beylot C. Oral contraceptives and cyproteron acetate in female acne treatment

//J. Jnvest. Dermatol. - 1997. - V.108. - P. 393.

83.Blake J.L., Hughes B.R., Cunliffe W.J. The effect of isotretinoin on sebum ex- cre-tion in acne: a 4 year study // J. Invest. Dermatol. - 1988. - V. 91, № 4. - P. 413.

84.Breiner W., Scheuber E., Plewig G. Effects of isotretinoin (13-cis-retinoic acid, Ro 4-3780) treatment on exfoliative cytology // Stratum corneum.- Berlin: SpringerVerlag, 1983. - P. 222-226.

85.Bryce G.F., Bogdan N.J., Brawn C.C. Retinoic acid promotes the repair of dermal damage and the effacement of wrinkles in the UMB-irradiated hairless mouse

//J. Invest. Dermatol. - 1988. - V. 91, № 2. - P. 175-180.

86.Carey B.M., Parkin G.J.S., Cunliffe W.J., et al. Skeletal toxity with isotretinoin therapy: clinico-radiological evaluation // Brit. J. Dermatol. - 1988. - V. 119, № 5. - P. 609-614.

87.Chan J.J., Rohr J.B. Acne vulgaris: yesterday, today and tomorrow // Austral. J. Dermatol. - 2000. - Nov., 41, Suppl. S. 69-72.

88.Chen W., Zouboulis C.C., Orfanos C.E. The 5-alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders // Dermatol. - 1996. - V. 193, № 3. - P.177-184.

89.Chu A.C. Retinoids today and tomorrow // Br. J. Dermatol. - 1995. - V. 4. - Р.

2-5.

90.Cibula D., Hill M., Vohradnikova O. et al. The role of androgens in determining acne severity in adult women // Br.J. Dermatol. - 2000. - V.143, №2.- P. 399-404.

143

91.Clucas A., Verschoore M., Sorba V. et al. Adapalene 0,1% gel is better tolerated than tretinoin 0,025% gel in acne patients // J. Am. Acad.Dermatol. - 1997. - V.36 (6 Pt 2). - P. 116-118.

92.Connor M.J., Lome N.J. Retinoid stimulation of epidermal cell growth in vivo

//Retinoids: new trends in research and therapy.- Basel: Karger, 1985. - P. 198-201.

93.Cosgarea R., Sasca N., Crisan C., et al. Efficiency of Corynebacterium parvum vaccine in acne // JEADV. - 1998. - V.11. - Suppl. 2. - P. 187-188.

94.Cunliffe W.J. Acne. - London: M. Dunitz, 1989. - 391 p.

95.Cunliffe W.J., Layton A.M. Oral isotretinoin: patient selection and management

//J. of Dermatological Treatment. - 1993. - V.4. - P. 10-15.

96.Cunliffe W.J. Adapalene 0,1% gel: Overview of international clinical experience // JEADV. - 1998. - V.11. - Suppl.2. - S. 100.

97.Cunliffe W.J., Holland D.B., Clark S.M., et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies // Br. J. Dermatol. - 2000. - V.142 № 6. - P. 1084-1091.

98.Deplewski D., Rosenfield R. Role of hormones in pilosebaceous unit development // Endocr. Rev. - 2000. - V. 21, № 4. - P. 363-392.

99.Dominguez J., Hojyo M.T., Celayo J.L. et al. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris // Int. J. Dermatol. - 1998. - V. 37, № 1. - P. 54-55.

100.Downing D.T., Stewart M.E, Wertz P.W. et al. Skin lipids: an update // J. Invest. Dermatol. - 1987. - V 88. - Suppl. 3. - S. 2-6.

101.Dreno B. Recent progress in acne pathogenesis and treatment // JEADV. - 1998. - V.11. - Suppl. 2. - P. 98-99.

102.Eady E.H., Ingham E., Wallers C.E. Modulation of comedonal levels of interleukin -1 in acne patients treated with tetracyclines // J. Invest. Dermatol. – 1993. - V.101. - P. 86-91.

103.Eichenfield L.F., Leyden J.J. Acne: current concepts of pathogenesis and approach to rational treatment // Pediatr. - 1991. - V. 18, № 3. - P. 218-223.

144

104.Elias P.M., Williams M.J. Retinoid effects on epidermal differentiation // Retinoids: new trends in research and therapy. - Basel: Karger, 1985. - P. 138-158.

105.Ellies P., Dighiero P., Legeais J.M. et al. Persistent corneal opacity after oral isotretinoin therapy for acne // Cornea. - 2000. - V.19, № 2. - P. 238-239.

106.Farrar M.D., Ingham E., Holland K.T. Heat shock proteins and inflammatory acne vulgaris // FEMS. Microbiol. Lett. - 2000. - V. 191, № 2. - S. 183-186.

107.Farrel L.H., Strauss J.S., Stranieri A.N. The treatment of severe cystic acne with 13- cis-retinoic acid // J. Am. Acad. Dermatol. - 1980. - V. 1. - P. 602-611.

108.Freidman S.L. Leukopenia and neutropenia associated with isotretinoin therapy // Arch. Dermatol. - 1987. - V. 123. - P. 293-295.

109.Fung W.K., Lo K.K. Prevalence of skin disease among school children and adolescents in a Student Health Service Center in Hong Kong // Pediatr.-Dermatol. - 2000. - V.17, № 6. - P. 440-446.

110.Geiger J.M. Retinoids and sebaceous gland activity // Dermatol. - 1995. - V. 191, № 4. - P. 305-310.

111.Germeraad W.F., Vasbinder H., Verbeeck A., et al. Vitamin A in acne vulgaris // Ned Tijdschr Geneeskd. - 1955. - V.99. - P. 2358-2364.

112.Greaves M.W., Dowd P.M., Hawk J.L.M. Dermatopharmacology: drugs around the corner // J. Am. Acad. Dermatol. - 1988. - V. 19, № 2 (part 1). - P. 323329.

113.Gomez E.C. Effects of retinoids on the sebaceous glands of the hamster flank organ // Retinoids: advances in basic research and therapy.- Berlin: Springer-Verlag, 1981. - P. 213-216.

114.Goulden V., Layton А.М., Cunliffe W.J. Long-term safety of isotretinoin as a treatment for acne vulgaris // Dermatolоgy. - 1995, № 190. - P. 284-287.

115.Harms M. // Systemic isotretinoin (active ingredient of Roaccutane).- Roche, Basel, Switzerland, 1994. – 93 p.

116.Heyman R.A., Mangelsdorf D.J., Dyck J.A. et al. 9-Cis retinoic acid is a high affinity ligand for the retinoid receptor // Cell. - 1992. - V. 68. - P. 397-406.

146

128.Kligman A.M., Fulton J.E., Plewig G. Topical vitamin A acid in acne vulgaris. // Arch. Dermatol. - 1969. - V. 99. - P. 469-476.

129.Kligman A.M. The treatment of acne with topical retinoids, one mans opinions

// J. Am. Acad. Dermatol. – 1997. – V.36, № 6. – P. 92-95.

130.Landthaler M., Kummermehr J., Wagner A. et al. Effects of 13-cis-retinoic acid on sebaceous glands in humans // Retinoids: advances in basic research and therapy.- Berlin: Springer-Verlag, 1981. - P. 259-266.

131.Layton A.M., Knaggs H, Taylor J. et al. Isotretinoin for acne vulgaris – 10 years later: A safe and successful treatment // Br. J. Dermatol. - 1993. - V.129. - P 292-296.

132.Leborwitz M.A., Berson D.S. Ocular effects of oral retinoids // J. Am. Acad. Dermatol. - 1988. - V. 19, № 1 (part 2). - P. 209-211.

133.Lehucher-Ceyrac D., Weber-Busset M. J. Isotretinoin and acne: A prospective analysis of 188 cases over 10 years // Dermatology. - 1993. - V. 186. - P. 123-128.

134.Leung L.H. Pantothenic acid deficiency as the pathogenesis of acne vulgaris // Med-Hypotheses. - 1995. - V. 44, № 6. - P. 490492.

135.Leyden J.J. Retinoids and acne. // J. Am. Acad. Dermatol. – 1988. - V. 19, №

1(part 2). - P. 164-168.

136.Leyden J.J. New understanding of the pathogenesis of acne // J. Am. Acad. Dermatol. - 1995. - V.32. - P 15-25.

137.Liden S. // Treatment of Acne: Workshop. - Stockholm. - 1996. - № 3. - Р. 21-

138.Lohnes D, Dierich A, Ghyselinck N. et al. Retinoid receptors and binding proteins // J. Cell Sсi. - 1992. - Suppl. 6. - P. 69-76.

139.Lucek R.W., Colburn W.A. Clinical Pharmacokinetics of the Retinoids // Clinical Pharmacokinetics. - 1985. - V.10, №1. - P. 38-62.

140.Madison K.C., Howard E.J. Ceramides are transported through the Goldi Apparatus in human keratinocytes in vitro // J. Invest.Dermatol. -1996. - V.106, № 5. - P. 1030-1035.

147

141.Mack A., Wokalek H., Maas B., et al. Use of isotretinoin in severe cases with papular pustular acne // Retinoid therapy. - Lancaster: MTP Press. - 1984. - P. 303311.

142.Marks R., Finlay A., Nicholls S., et al. The effects of retinoids on stratum corneum // Retinoids: advances in basic research and therapy. - Berlin: SpringerVerlag, 1981. - P. 77-83.

143.Meigel W., Gollnick H., Wokalek H., et al. Orale Behandlung der Acne conglobata mit 13-cis-Retinsaure // Hautarzt. - 1983, H. 34. - S. 387-397.

144.Melnik B.C., Bros U., Plewig G. Evaluation of the atherogenic risk of isotretinoin – induced alterations of lipoprotein cholesterol metabolism // J. Invest. Dermatol. – 1987. - V. 87, № 3 (suppl.). - P. 39-43.

145.Melnik B.C., Plewig G. Neue lipidbiochemische Aspekte in der Pathogenese der follikulären Verhornungsstörung bei Acne vulgaris // Z. Hautkr. – 1988. -H. 63,

№7. - S. 591-596.

146.McKerrow K.J., Mackie R.M., Lesko M.J., et al. The effect of oral retinoid therapy on the normal human immune system // Br. J. Dermatol. - 1988.- V. 119, №

3.- P. 313-320.

147.Michel S., Jomard A., Demarchez M. Pharmacology of adapalene // Br. J. Dermatol. – 1998. - V. 139., suppl. 52. – P. 3-7.

148.Niemer V., Kupfer J., Demchbauer-Ebner M. et al. Coping with acne vulgaris // Dermatologу. - 1998. - V.196. - P.108-115.

149.Orfanos C.E., Zouboulis C.C., Almond-Roesler B., et al. Current use and future potential role of retinoids in dermatology // Drugs. - 1997. - V. 53, № 3. - P.358-

150.Orfanos C.E., Zouboulis C.C. Oral retinoids in the treatment of seborrhoea and acne // Dermatol. - 1998. - V. 196, № 1. - P. 140-147.

151.Panconesi E., Hautmann G. Psychotherapeutic approach in acne treatment //Dermatol. - 1998. - V. 196, № 1. - P. 116-118.

152.Passi S., Picardo M., De Luca C., et al. Mechanism of azelaic acid action in acne // G. Ital. Dermatol.Venereol.-1989.- V.124, № 10.- P.455-463.

148

153.Patel V.B., Misra A., Marfatia Y.S. Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications // Pharm. Dev. Technol. - 2000. - V. 5, № 4. - P. 455-464.

154.Peck G.L., Olson T.G., Yoder F.W. et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid // New Engl. J. Med. – 1979. - V. 300, № 7. - P. 329-333.

155.Peck G.L., Gross E.G., Butkus D. Comparative analysis of two retinoids in the treatment of disorders of keratinization // Retinoids: advances in basic research and therapy. - Berlin: Springer-Verlag, 1981. - P. 279-286.

156.Plewig G., Gollnick H., Meigel W. et al. 13-cis-Retinsäure zur oralen Behandlung der Acne conglobata // Hautarzt. - 1981. - H. 32. - S. 634-646.

157.Plewig G., Kligman A.M. Acne and rosacea. - Berlin: Springer-Verlag, 1993.-

726 p.

158.Pochi P.E., Shalita A.R., Strauss J.S., et al. Report of conference on acne classification // J. Am. Acad. Dermatol. - 1991. - V.24, № 3. - P.495-500.

159.Ponec M., Kempensar J., Weerheim A., et al. Modulating effects of retinoic acid on keratin expression and lipid composition of normal keratinocytes cultured on air-liquid interface // J. Invest. Dermatol. - 1988. - V. 91, № 4. - P. 389.

160.Riamondo V., Ubels J.L., Osgood T.B. Tear secretion and lacrimal gland function of rabbits treated with isotretinoin // J. Am. Acad. Dermatol. - 1988. - V. 19, № 2 (part 2). - P. 280-285.

161.Roenigk H.H. Liver toxicity of retinoid therapy // J. Am. Acad. Dermatol. – 1988. - V. 19, № 1 (part 2). - P. 199-208.

162.Rothman K.F., Pochi P.E. Use of oral and topical agents for acne in pregnancy. // J. Am. Acad. Dermatol. - 1988. - V. 16, № 3. - P. 421-423.

163.Sanquer S., Coulomb B., Lebreton Cc., et al. Retinoid modulate the dermoepidermal interactions on the skin equivalent culture model // J. Invest. Dermatol. - 1988. - V. 91, № 4. - P. 379.

149

164.Saurat J.H., Hirschel-Scholz S. Isotretinoin differs from other syntetic retinoids in its modulation of cellular retinoic acid binding protein (CRABP) after oral but not after topical administration // J. Invest. Dermatol. - 1988. - V. 91, № 4. - P. 389.

165.Saurat J.H. // Retinoid Symp. Suppl. Retinoids today and tomorrow.- Basel, Roche, 1992. - P. 2-5.

166.Schaefer H. Penetration and percutaneous absorption of topical retinoids // Skin Pharmacol. - 1993. - V. 6, suppl. 1. - P. 17-23.

167.Schafer-Korting M., Korting H.C., Ponce-Poschl E. Liposomal tretinoin for uncomplicated acne vulgaris // Clin. Invest. - 1994. - V. 72, № 12. - P. 1086-1091.

168.Schmidt J.B., Spona J., Niebauer G. Haut-Lipide wahrend 13-cis-Retinoid- Therapie bei Akne // Z. Hautkr. - 1983. - H. 58, № 24. - S. 1744-1753.

169.Schultz-Ehrenburg U., Orfanos C.E. Light and electron microscopic changes of human epidermis under oral retinoid treatment // Retinoids: advances in basic research and therapy.- Berlin: Springer-Verlag, 1981. - P. 85-92.

170.Schumacher A., Stuttgen G. Vitamin-A Saure bei Hyperkeratosen epithelialen Tumoreu and Akne // Dtsch. Med. Wochenschr. - 1971. - V.40. - P.1547-1551.

171.Sendagorta E. // Retinoid Symp.Suppl. Retinoids today and tomorrow. - Basel, Roche, 1992. - P. 37-41.

172.Shalita A.R. // Retinoid Symp.Suppl. Retinoids today and tomorrow. - Basel, Roche, 1992. - P. 13-15.

173.Shuttlerworth D., Holt P.J.A., Mathews N. Hyperimmunoglobulin E syndrome: treatment with isotretinoin // Br. J. Dermatol. - 1988. - V. 119, № 1. - P. 9399.

174.Siegenthaller G., Saurat J. – H., Hotz R., et al. Plasma transport of retinoids used in human therapy // J. Invest. Dermatol. - 1987. - V. 89, № 3. - P. 311.

175.Simpson N., Brown-Douglas D., Hodgins M.B. Isotretinoin and androgen metabolism in human back skin // J. Invest. Dermatol. - 1987. - V. 89, № 3. - P. 326.

176.Sporn M.B., Roberts A.B. What is a retinoid? // Retinoids, differentiation and disease. Ciba Faundation Symposium.- London: Pitman, 1985, № 113. - Р. 1-5.

150

177.Stewart M.E. Sebaceous gland lipids // Semin. Dermatol. - 1992. - V.11, № 2

-P. 100-105.

178.Straumfjord J.V. Vitamin A: its effect on acne:A study of 100 patients // Northwest Med. - 1949. - V. 42. - P.219-225.

179.Strauss J.S., Thamsen R.J., Farrel L.M., et al. Oral retinoids: effects on human sebaceous glands and nodulocytic acne // Retinoids: advances in basic research and therapy.- Berlin: Springer-Verlag, 1981. - P. 237-243.

180.Strauss J.S., Cunningham W.J., Leyden J.J. et al. Isotretinoin and teratogenicity // J. Am. Dermatol. - 1988. - V. 19, № 2 (part 1). - P. 237-243.

181.Strauss J.S. Sebaceous Glands // Dermatology. NY: McGraw-Hill, 1993. - P. 709-726.

182.Strauss J.S. Pathogenesis of Acne // Intern. Meeting on clinical dermatology “Hot Line”, Greece, 1996. - P. 10-13.

183.Tan J.K. Perspectives on isotretinoin and the Canadian Consensus Guidelines on treatment of acne // Skin.Therapy. Lett. - 2000. - V. 6, № 2. - P. 1-4.

184.Tammi R., Ripelino J.A., Mergolis R.U. et al. Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture // J. Invest. Dermatol. – 1989. - V. 92, № 3. - P. 99-108.

185.Thiboutot D., Harris G., Iles V., et al. Activity of the type I 5-alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin // J. Invest. Dermatol. – 1995. - V. 105, № 2. - P. 209-214.

186.Thiboutot D., Bayne E., Thorne J., et al. Immunolocalization of 5-alfa- reductase isozymes in acne lesions and normal skin // Arch. Dermatol. - 2000. - V. 136, № 9. - Р. 1125-1129.

187.Till A.E., Goulden V., Cunliff W.J., et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ // Br. J.- Dermatol. - 2000.

-V. 142, № 5. - P. 885-892.

188.Tsamboas D., Orfanos C.E. Chemotherapy of psoriasis and other skin disoders with oral retinoids // The chemotherapy of psoriasis.- Oxford: Pergamon Press, 1984. - P. 287-306.